Patents by Inventor Akira Kikuchi
Akira Kikuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240329345Abstract: A core portion of each of optical fibers of an optical fiber cable is made of pure silica glass, an effective cross-sectional area of the core portion at a wavelength of 1550 nm is 110 ?m2 or more and 150 ?m2 or less. The optical fibers include an intermittent connection portion in which a connection portion to which an adhesive resin is applied and a non-connection portion to which the adhesive resin is not applied are alternately provided between adjacent optical fibers. The optical fiber ribbon has a ratio of a total adhesion length to which the adhesive resin is applied to a total length between all the optical fibers of 40% or more per a unit length of the optical fiber ribbon, and an occupancy ratio of the optical fiber ribbon to a cross-sectional area of the internal space is 30% or more and 40% or less.Type: ApplicationFiled: August 24, 2022Publication date: October 3, 2024Inventors: Yutaka HASHIMOTO, Fumiaki SATO, Masashi KIKUCHI, Soichi ISHIKAWA, Akira SAKURAI, Yusuke YAMADA, Sadaharu HOMAN
-
Patent number: 12108690Abstract: A quantum device capable of securing terminals for external connection is provided. A quantum device according to an example embodiment includes a quantum chip 10, an interposer 20 on which the quantum chip 10 is mounted, and a socket 40 disposed so as to be opposed to the interposer 20, the socket 40 comprising a movable pin 47 and a housing 45 supporting the movable pin 47, in which at least one end of the movable pin 47, which includes the one end and the other end opposite to the one end, is movable relative to the housing 45, the one end being in electrical contact with a terminal of the interposer 20, and the other end is in an electrical contact with a terminal of a board 50 on which a connector 51 is formed, the connector 51 being configured to serve as an external input/output.Type: GrantFiled: June 15, 2021Date of Patent: October 1, 2024Assignee: NEC CORPORATIONInventors: Katsumi Kikuchi, Akira Miyata, Suguru Watanabe, Takanori Nishi, Hideyuki Satou, Kenji Nanba, Ayami Yamaguchi
-
Patent number: 12094812Abstract: A quantum device capable of improving a cooling effect while securing the number of terminals is provided. A quantum device according to an example embodiment includes a quantum chip 10, and an interposer 20 on which the quantum chip 10 is mounted, in which the interposer 20 includes a conductive wiring line CL1 electrically connected to the quantum chip 10, and a metal film 70 disposed in a part of the interposer 20 that is in contact with a sample stage 30 having a cooling function, and a mounting surface 21 of the interposer 20 on which the quantum chip 10 is mounted or an opposite surface 22 opposite to the mounting surface 21 includes a first area AR11 and a second area AR12 different from the first area AR11 as viewed in a direction perpendicular to the mounting surface 21 or the opposite surface 22.Type: GrantFiled: June 11, 2021Date of Patent: September 17, 2024Assignee: NEC CORPORATIONInventors: Katsumi Kikuchi, Akira Miyata, Suguru Watanabe, Takanori Nishi, Hideyuki Satou, Kenji Nanba, Ayami Yamaguchi
-
Publication number: 20240302620Abstract: An optical fiber cable according to the present disclosure includes a cable core having one or a plurality of optical fiber core wires therein; an outer cover which covers the cable core and has a concave portion or a plurality of convex portions for an outer edge of a cross section perpendicular to a long axis direction of the outer cover; and an impression which is marked on the concave portion or on a portion sandwiched between the plurality of convex portions of a side surface of the outer cover.Type: ApplicationFiled: May 31, 2021Publication date: September 12, 2024Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATIONInventors: Masashi KIKUCHI, Shigekatsu TETSUTANI, Yusuke YAMADA, Akira SAKURAI, Hiroaki TANIOKA
-
Publication number: 20240288656Abstract: In order to achieve the foregoing object, the optical cable laying method of the present disclosure lays an optical cable on a road surface or a wall surface so that the optical cable passes through two points along a route therebetween longer than a minimum distance therebetween.Type: ApplicationFiled: June 16, 2021Publication date: August 29, 2024Applicant: NIPPON TELEGRAPH AND TELEPONE CORPORATIONInventors: Akira SAKURAI, Hiroaki TANIOKA, Shigekatsu TETSUTANI, Yusuke YAMADA, Masashi KIKUCHI
-
Publication number: 20240288647Abstract: In order to achieve the above-mentioned object, an optical fiber cable according to the present disclosure includes an optical fiber core wire, a sheath covering the optical fiber core wire, three or more anti-tension members inside the sheath, arranged along a longitudinal axis of the optical fiber core wire, and a tear string having an outer periphery a part of which is located outside an outer circumscribed lines of outer peripheries of the three or more anti-tension members in certain cross-sections perpendicular to a longitudinal direction of the sheath, and a part of which comes in contact with an inner periphery of the sheath or is located inside the inner periphery of the sheath in a cross-section perpendicular to the longitudinal direction of the sheath.Type: ApplicationFiled: June 18, 2021Publication date: August 29, 2024Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATIONInventors: Akira SAKURAI, Hiroaki TANIOKA, Shigekatsu TETSUTANI, Yusuke YAMADA, Masashi KIKUCHI
-
Patent number: 12071624Abstract: The purpose of the present invention is to provide an antisense oligonucleotide that targets an ARL4C molecule and exerts an antitumor effect in vivo, and a nucleic acid drug using the antisense oligonucleotide. An antisense oligonucleotide that has a base sequence consisting of at least 10 consecutive bases contained in the base sequence represented by SEQ ID NO: 1. This antisense oligonucleotide targets an ARL4C molecule and thus can inhibit the expression of ARL4C in a tumor cell in vitro and suppress the migration and proliferation thereof. When systemically administered, moreover, the antisense oligonucleotide can exert an excellent antitumor effect in vivo too.Type: GrantFiled: September 4, 2019Date of Patent: August 27, 2024Assignees: Osaka University, National Institutes of Biomedical Innovation, Health and Nutrition, National University Corporation Kobe UniversityInventors: Akira Kikuchi, Shinji Matsumoto, Satoshi Obika, Yuya Kasahara, Takumi Fukumoto
-
Publication number: 20240272394Abstract: An optical fiber cable according to the present disclosure includes: a cable core having a plurality of optical fiber core wires; a sheath covering the cable core; and at least two or more tension members, having warping ability outward from an axial center of a cable core, disposed inside the sheath along the cable core, and any one of the tension members is disposed at a position laying along a position of another of the tension members with the axial center of the cable core sandwiched between the positions.Type: ApplicationFiled: May 31, 2021Publication date: August 15, 2024Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATIONInventors: Masashi KIKUCHI, Shigekatsu TETSUTANI, Yusuke YAMADA, Akira SAKURAI, Hiroaki TANIOKA
-
Publication number: 20240248001Abstract: An object of the present invention is to provide an optical fiber testing method and an optical fiber winding device capable of appropriately reproducing the same lateral pressure and minute bending state in a test of an optical fiber as those in an optical cable. In the optical fiber testing method according to the present invention, an optical fiber 51-2 of the second layer wound around a bobbin 12 is used as an object to be tested. Lateral pressure to the optical fiber 51-2 of the second layer is applied by an optical fiber 51-3 of the third layer. The lateral pressure is adjusted by a tension when the optical fiber 51-3 of the third layer is wound around the bobbin. In other words, since the lateral pressure is applied to the optical fiber to be tested from another optical fiber, the same lateral pressure and minute bending state as those in the optical cable can be reproduced.Type: ApplicationFiled: May 31, 2021Publication date: July 25, 2024Applicant: NIPPON TELEGRAPH AND TELEPHONE CORPORATIONInventors: Yusuke YAMADA, Masashi KIKUCHI, Akira SAKURAI, Shigekatsu TETSUTANI, Hiroaki TANIOKA
-
Patent number: 12037160Abstract: Provided are a packaging container, a packaging method, and a method for carrying metal foil, which can suppress damage and deformation of the packaging container and enable stable carrying even if the packaging container is carried while suspending it in the midair. A packaging container made of corrugated cardboard includes: a pallet 2 having leg portions 21; a body frame 3 arranged on the pallet 2, the body frame 3 having bearing grooves 31 at end wall portions 32 opposing to each other; and a lid portion 4 provided on the body frame 3, wherein each of the leg portions 21 is arranged on an inner side than each of the end wall portions 23 of the pallet 2.Type: GrantFiled: January 22, 2021Date of Patent: July 16, 2024Assignee: JX Advanced Metals CorporationInventors: Akira Sako, Yasunobu Miyata, Kazuhiko Kikuchi
-
Patent number: 11942873Abstract: A secondary magnetic excitation generator-motor device that inputs a first ignition pulse command to a three-level NPC power converter such that a detected excitation current value corresponds with an excitation current command value, the secondary magnetic excitation generator-motor device having a function of identifying a first phase, a second phase, or a third phase in descending order of a current absolute value, wherein a pulse switch to output an ignition pulse command to the three-level NPC power converter switches the ignition pulse command to the second ignition pulse command when a current absolute value exceeds a set overcurrent level 1, and switches the ignition pulse command to the first ignition pulse command when current absolute values for three phases are all equal to or smaller than a set overcurrent level 2.Type: GrantFiled: August 8, 2019Date of Patent: March 26, 2024Assignees: HITACHI MITSUBISHI HYDRO CORPORATION, HITACHI, LTD.Inventors: Akira Bando, Hironari Kawazoe, Akira Kikuchi
-
Publication number: 20240039414Abstract: Provided is a power conversion device that can be realized with a small circuit and is capable of stably converting AC power inputted from a three-phase power source system into DC power. In a power conversion device: an output terminal of a common converter cell in a J-numbered stage is connected, together with output terminals of common converter cells of the other two phases, to common lines; an output terminal of an independent converter cell in a K-numbered stage is connected to independent lines independently of converter cells of the other two phases; and a plurality of switches comprise a common switch for switching the connection relationship between the common lines and DC buses, and an independent switch for switching the connection relationship between the independent lines and DC buses.Type: ApplicationFiled: May 7, 2021Publication date: February 1, 2024Inventors: Akira KIKUCHI, Akihiko KANOUDA
-
Patent number: 11807679Abstract: The purpose of the present invention is to provide an anti-CKAP4 monoclonal antibody that inhibits the binding of DKK1 and CKAP4 and exhibits an exceptional antitumor effect. Provided is an anti-CKAP4 monoclonal antibody that recognizes at least part of the 451-455 region, at least part of the 481-485 region, at least part of the 502-510 region, at least part of the 503-524 region and at least part of the 585-590 region, or at least part of the 585-592 region of the amino acid sequence (amino acid sequence of CKAP4) represented by SEQ ID NO:1 as an epitope, the anti-CKAP4 monoclonal antibody effectively inhibiting the binding of DKK1 and CKAP4, the activation of AKT of S2-CP8 cells, and the proliferative ability of S2-CP8 cells or the migratory ability of S2-CP8 cells, and exhibiting an exceptional antitumor effect.Type: GrantFiled: September 26, 2018Date of Patent: November 7, 2023Assignee: OSAKA UNIVERSITYInventors: Akira Kikuchi, Katsumi Fumoto, Hirokazu Kimura
-
Publication number: 20220249538Abstract: The purpose of the present invention is to provide a novel tumor treatment agent. In GREB1-positive tumors that do not exhibit sex hormone sensitivity, GREB1 is a downstream target gene of the Wnt/?-catenin signal. Through the use as an active ingredient of a substance that can inhibit GREB1 expression, the growth of GREB1-positive tumor cells that do not exhibit sex hormone sensitivity can be effectively inhibited and such a tumor can be treated.Type: ApplicationFiled: May 22, 2020Publication date: August 11, 2022Inventors: Akira Kikuchi, Shinji Matsumoto, Taku Yamamichi
-
Publication number: 20220231615Abstract: A secondary magnetic excitation generator-motor device that inputs a first ignition pulse command to a three-level NPC power converter such that a detected excitation current value corresponds with an excitation current command value, the secondary magnetic excitation generator-motor device having a function of identifying a first phase, a second phase, or a third phase in descending order of a current absolute value, wherein a pulse switch to output an ignition pulse command to the three-level NPC power converter switches the ignition pulse command to the second ignition pulse command when a current absolute value exceeds a set overcurrent level 1, and switches the ignition pulse command to the first ignition pulse command when current absolute values for three phases are all equal to or smaller than a set overcurrent level 2.Type: ApplicationFiled: August 8, 2019Publication date: July 21, 2022Inventors: Akira BANDO, Hironari KAWAZOE, Akira KIKUCHI
-
Patent number: 11293007Abstract: A method for producing a Wnt protein-afamin complex, the method comprising the steps of culturing Wnt protein-expressing cells in a culture medium containing a purified afamin or a recombinant afamin or co-culturing Wnt protein-expressing cells and recombinant afamin-expressing cells or culturing cells expressing both a Wnt protein and afamin; obtaining the culture supernatant; and optionally performing affinity purification to obtain the Wnt protein-afamin complex from the culture supernatant.Type: GrantFiled: September 10, 2019Date of Patent: April 5, 2022Assignee: OSAKA UNIVERSITYInventors: Junichi Takagi, Emiko Mihara, Akira Kikuchi
-
Publication number: 20210317459Abstract: The purpose of the present invention is to provide an antisense oligonucleotide that targets an ARL4C molecule and exerts an antitumor effect in vivo, and a nucleic acid drug using the antisense oligonucleotide. An antisense oligonucleotide that has a base sequence consisting of at least 10 consecutive bases contained in the base sequence represented by SEQ ID NO: 1. This antisense oligonucleotide targets an ARL4C molecule and thus can inhibit the expression of ARL4C in a tumor cell in vitro and suppress the migration and proliferation thereof. When systemically administered, moreover, the antisense oligonucleotide can exert an excellent antitumor effect in vivo too.Type: ApplicationFiled: September 4, 2019Publication date: October 14, 2021Inventors: Akira KIKUCHI, Shinji MATSUMOTO, Satoshi OBIKA, Yuya KASAHARA, Takumi FUKUMOTO
-
Patent number: 11088569Abstract: The purpose of the present invention is to provide a power flow monitoring device for a power system, a power system stabilization device, and a power flow monitoring method for a power system, which are highly reliable and accurate.Type: GrantFiled: September 13, 2017Date of Patent: August 10, 2021Assignee: Hitachi, Ltd.Inventors: Yuki Tsujii, Kenedward Kawakita, Masatoshi Kumagai, Masahiro Watanabe, Akira Kikuchi
-
Patent number: 10873273Abstract: An apparatus includes: an inverter converting generated power of renewable energy resources to predetermined alternating-current power for output to a power transmission network; a PWM control unit controlling the inverter; a first detecting unit detecting the input voltage and current to the inverter; a second detecting unit detecting the output voltage, current, and frequency of the inverter; a power change deciding unit calculating the input and output powers of the inverter and the difference therebetween from the voltage and current of each of the input and output detected by the detecting units, and calculating a correction output power command with reference to an output power command; and a virtual synchronous inertia control unit calculating a virtual inertia characteristic based on the voltage, current, and frequency of the output detected by the second detecting unit and the correction output power command, and outputting a reference command to a PWM control unit.Type: GrantFiled: March 21, 2018Date of Patent: December 22, 2020Assignee: Hitachi, Ltd.Inventors: Chia Tse Lee, Akira Kikuchi
-
Publication number: 20200377580Abstract: The purpose of the present invention is to provide an anti-CKAP4 monoclonal antibody that inhibits the binding of DKK1 and CKAP4 and exhibits an exceptional antitumor effect. Provided is an anti-CKAP4 monoclonal antibody that recognizes at least part of the 451-455 region, at least part of the 481-485 region, at least part of the 502-510 region, at least part of the 503-524 region and at least part of the 585-590 region, or at least part of the 585-592 region of the amino acid sequence (amino acid sequence of CKAP4) represented by SEQ ID NO:1 as an epitope, the anti-CKAP4 monoclonal antibody effectively inhibiting the binding of DKK1 and CKAP4, the activation of AKT of S2-CP8 cells, and the proliferative ability of S2-CP8 cells or the migratory ability of S2-CP8 cells, and exhibiting an exceptional antitumor effect.Type: ApplicationFiled: September 26, 2018Publication date: December 3, 2020Inventors: Akira KIKUCHI, Katsumi FUMOTO, Hirokazu KIMURA